Butinib Capsule 140 mg contains Ibrutinib, a targeted anticancer medication classified as a Bruton’s tyrosine kinase (BTK) inhibitor. It is used in the treatment of certain types of B-cell malignancies. By specifically targeting and inhibiting BTK, a key enzyme involved in B-cell signaling, Ibrutinib helps block the growth and survival of cancerous B cells, thereby slowing disease progression.

Unlike traditional chemotherapy, Ibrutinib works through targeted therapy, focusing on specific molecular pathways involved in cancer development. This mechanism allows it to effectively control disease while often being better tolerated compared to conventional cytotoxic treatments.

Butinib Capsule 140 mg is typically prescribed as part of long-term treatment plans under the supervision of an oncologist or hematologist.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Butinib Capsule 140 mg is indicated for the treatment of certain hematological malignancies, including:

• Chronic lymphocytic leukemia (CLL)

• Small lymphocytic lymphoma (SLL)

• Mantle cell lymphoma (MCL)

• Waldenström’s macroglobulinemia (WM)

• Marginal zone lymphoma (MZL)

• Chronic graft-versus-host disease (cGVHD), in specific cases

Treatment decisions are based on disease type, stage, and patient-specific clinical factors.

Key Benefits

• Targeted BTK inhibitor for B-cell cancers

• Oral administration for convenient long-term therapy

• Helps slow disease progression

• Suitable for monotherapy or combination therapy depending on clinical indication

• May improve progression-free survival in eligible patients

Dosage and Administration

The dosage of Butinib Capsule is determined by the specific condition being treated and the patient’s clinical status. It should be taken exactly as prescribed by a qualified healthcare professional.

General guidelines:

• Swallow the capsule whole with a glass of water

• Take at the same time each day

• Do not open, break, or chew the capsule

• Continue treatment as directed, even if symptoms improve

Dose modifications may be required in cases of adverse reactions or when used with certain other medications.

Precautions

Before starting Butinib, inform your doctor if you have:

• Bleeding disorders

• Heart rhythm problems

• High blood pressure

• Liver impairment

• Active infections

Ibrutinib may increase the risk of bleeding and infections. Patients should be monitored regularly with laboratory tests during treatment. Avoid use with strong CYP3A inhibitors or inducers unless directed by a physician.

Use during pregnancy is not recommended. Effective contraception should be used during treatment and for a period after discontinuation as advised by the healthcare provider.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects may include:

• Diarrhea

• Fatigue

• Nausea

• Muscle or joint pain

• Bruising or minor bleeding

Serious side effects can include severe bleeding, heart rhythm abnormalities (such as atrial fibrillation), infections, or low blood cell counts. Immediate medical attention is required if severe reactions occur.

Storage

Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.

Butinib Capsule 140 mg provides an advanced, targeted treatment option for specific B-cell malignancies, supporting effective disease control under specialized medical supervision.